BR112017017894A2 - composições de alérgenos misturados e métodos para usar as mesmas - Google Patents

composições de alérgenos misturados e métodos para usar as mesmas

Info

Publication number
BR112017017894A2
BR112017017894A2 BR112017017894A BR112017017894A BR112017017894A2 BR 112017017894 A2 BR112017017894 A2 BR 112017017894A2 BR 112017017894 A BR112017017894 A BR 112017017894A BR 112017017894 A BR112017017894 A BR 112017017894A BR 112017017894 A2 BR112017017894 A2 BR 112017017894A2
Authority
BR
Brazil
Prior art keywords
allergen
mixed allergen
mixed
methods
compositions
Prior art date
Application number
BR112017017894A
Other languages
English (en)
Inventor
C Nadeau Kari
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017017894(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of BR112017017894A2 publication Critical patent/BR112017017894A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

composições de alérgenos misturados de dois ou mais alérgenos diferentes são fornecidas. em alguns casos, as composições de alérgeno misturado incluem: um alérgeno de noz; um alérgeno de animal; e pelo menos um entre: um alérgeno de planta não de noz; um agente biótico e uma vitamina. são também fornecidos métodos de administrar as composições de alérgenos misturados em um sujeito. as composições de alérgenos misturados encontram uso em uma variedade de aplicações, incluindo manutenção de saúde, equilíbrio imunológico, equilíbrio de intestino, suporte imunológico, melhora de saúde e aplicações terapêuticas.
BR112017017894A 2015-02-20 2016-02-19 composições de alérgenos misturados e métodos para usar as mesmas BR112017017894A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
PCT/US2016/018731 WO2016134291A2 (en) 2015-02-20 2016-02-19 Mixed allergen compositions and methods for using the same

Publications (1)

Publication Number Publication Date
BR112017017894A2 true BR112017017894A2 (pt) 2018-04-10

Family

ID=56689334

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017894A BR112017017894A2 (pt) 2015-02-20 2016-02-19 composições de alérgenos misturados e métodos para usar as mesmas

Country Status (23)

Country Link
US (4) US10064936B2 (pt)
EP (2) EP4186521A1 (pt)
JP (3) JP6859261B2 (pt)
KR (1) KR20170117562A (pt)
CN (2) CN107405394B (pt)
AU (2) AU2016219793C1 (pt)
BR (1) BR112017017894A2 (pt)
CA (1) CA2977127A1 (pt)
DK (1) DK3258962T3 (pt)
ES (1) ES2937287T3 (pt)
FI (1) FI3258962T3 (pt)
HK (1) HK1247854A1 (pt)
HU (1) HUE061576T2 (pt)
IL (1) IL253976B1 (pt)
LT (1) LT3258962T (pt)
MA (1) MA41558B1 (pt)
MX (2) MX2017010697A (pt)
PL (1) PL3258962T3 (pt)
PT (1) PT3258962T (pt)
RS (1) RS63941B1 (pt)
SG (2) SG11201706734SA (pt)
SI (1) SI3258962T1 (pt)
WO (1) WO2016134291A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201706734SA (en) 2015-02-20 2017-09-28 Univ Leland Stanford Junior Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) * 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
CN110114062B (zh) * 2016-11-21 2023-04-07 雀巢产品有限公司 液体变应原组合物和制备其的方法
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
SG10201913846XA (en) * 2017-01-13 2020-03-30 Aimmune Therapeutics Inc Methods of manufacture of nut flours and formulations for oral immunotherapy
FR3062797A1 (fr) * 2017-02-10 2018-08-17 Centre Hospitalier Et Universitaire De Clermont-Ferrand Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
SG11202000419QA (en) * 2017-07-18 2020-02-27 Before Brands Inc Methods for making mixed allergen compositions
WO2019112808A1 (en) 2017-12-06 2019-06-13 Prollergy Corporation Composition and method for reducing allergic response
CA3120763A1 (en) * 2018-11-30 2020-06-04 Alladapt Immunotherapeutics, Inc. Methods for making mixed allergen compositions
US20220071899A1 (en) * 2018-12-21 2022-03-10 SOCIETE DES PRODUlTS NESTLE S.A. Drinkable infant compositions
CN113507844A (zh) 2019-01-23 2021-10-15 前品牌股份有限公司 制备混合型过敏原组合物的方法
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US20240151702A1 (en) * 2021-03-05 2024-05-09 Societe Des Produits Nestle S.A. Methods of making and assessing allergenic tree nut compositions
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
WO2001040264A2 (en) 1999-12-06 2001-06-07 Panacea Pharmaceuticals, Llc. Peptide antigens
US6716471B2 (en) 2000-05-12 2004-04-06 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (fr) 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
DE602004032025D1 (de) 2003-06-23 2011-05-12 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
US8491909B2 (en) * 2004-02-06 2013-07-23 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
AU2007219127A1 (en) 2006-02-27 2007-08-30 South Georgia Pecan Company Animal food composition comprising nut shell
EP1872792A1 (en) 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101646418B (zh) * 2006-10-12 2013-07-17 昆士兰大学 调节免疫应答的组合物和方法
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US20100278880A1 (en) 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
PT2244734T (pt) 2008-02-01 2016-08-05 Murdoch Childrens Res Inst Método para induzir tolerância a um alérgeno
EP2140880B1 (en) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification of allergens
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (ja) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 可溶性凝集体、免疫寛容誘導剤及びその製造方法
US9049881B2 (en) * 2009-08-18 2015-06-09 Nestec S.A. Nutritional composition comprising lactococcus strains and reducing allergy symptoms, especially in infants and children
WO2011026966A2 (en) * 2009-09-07 2011-03-10 Dbv Technologies Method of treating eosinophilic esophagitis
CN102048077A (zh) 2009-10-30 2011-05-11 梁振 一种方便营养果丁豆花
EP3305319A1 (en) * 2010-04-30 2018-04-11 Allovate, LLC Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
US9271899B2 (en) 2010-04-30 2016-03-01 Allovate, Llc Methods, articles and kits for allergic desensitization, via the oral mucosa
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
JP2013544784A (ja) 2010-10-15 2013-12-19 アルク−アベッロ エイ／エス アレルゲン供給源物質に由来する非関連抗原を用いる超過敏性免疫応答の抑制
GB201104537D0 (en) 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (zh) 2012-12-11 2013-03-27 崔杰 一种花生核桃咸饼的制作方法
US9198869B2 (en) 2013-03-14 2015-12-01 Aimmune Therapeutics, Inc. Manufacture of peanut formulations for oral desensitization
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
BR112015024040A2 (pt) 2013-03-19 2017-07-18 Biotech Tools Sa preparação alergênica
RU2015155874A (ru) 2013-06-06 2017-07-14 Анержи С.А. Смежные перекрывающиеся пептиды для лечения аллергии, вызванной клещами домашней пыли
KR102385900B1 (ko) 2013-09-19 2022-04-11 알로베이트, 엘엘씨 구강점막으로 알레르겐을 전달하기 위한 치약
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
EP4275760A3 (en) 2014-08-25 2024-02-07 Société des Produits Nestlé S.A. Egg protein formulations and methods of manufacture thereof
CN104273238A (zh) * 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 一种芝麻酱干及其制备方法
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
SG11201706734SA (en) 2015-02-20 2017-09-28 Univ Leland Stanford Junior Mixed allergen compositions and methods for using the same
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens

Also Published As

Publication number Publication date
MX2017010697A (es) 2017-11-17
EP4186521A1 (en) 2023-05-31
HUE061576T2 (hu) 2023-07-28
PL3258962T3 (pl) 2023-04-24
US20190038741A1 (en) 2019-02-07
KR20170117562A (ko) 2017-10-23
CN107405394A (zh) 2017-11-28
EP3258962A4 (en) 2018-07-11
US9731003B2 (en) 2017-08-15
JP6859261B2 (ja) 2021-04-14
US10064936B2 (en) 2018-09-04
EP3258962A2 (en) 2017-12-27
RS63941B1 (sr) 2023-02-28
WO2016134291A2 (en) 2016-08-25
US20160243217A1 (en) 2016-08-25
AU2022201699A1 (en) 2022-04-07
AU2016219793C1 (en) 2022-03-17
ES2937287T3 (es) 2023-03-27
MA41558A (fr) 2017-12-26
AU2016219793A1 (en) 2017-08-31
US20170056494A1 (en) 2017-03-02
IL253976A0 (en) 2017-10-31
SG10201909093XA (en) 2019-11-28
WO2016134291A3 (en) 2016-10-13
JP2018505907A (ja) 2018-03-01
IL253976B1 (en) 2024-05-01
SG11201706734SA (en) 2017-09-28
FI3258962T3 (fi) 2023-04-12
PT3258962T (pt) 2023-02-16
US20220133882A1 (en) 2022-05-05
MA41558B1 (fr) 2023-02-28
LT3258962T (lt) 2023-02-27
CA2977127A1 (en) 2016-08-25
EP3258962B1 (en) 2022-11-02
SI3258962T1 (sl) 2023-07-31
AU2016219793B2 (en) 2021-12-16
HK1247854A1 (zh) 2018-10-05
JP2022125346A (ja) 2022-08-26
DK3258962T3 (da) 2023-02-06
CN114129720A (zh) 2022-03-04
MX2022008663A (es) 2022-08-10
JP2021046445A (ja) 2021-03-25
CN107405394B (zh) 2021-12-14

Similar Documents

Publication Publication Date Title
BR112017017894A2 (pt) composições de alérgenos misturados e métodos para usar as mesmas
CL2020002269A1 (es) Anticuerpo que se une a redil33; polinucleótido; vector; célula hospedadora; método para producir el anticuerpo; composición farmacéutica; producto de combinación; uso del anticuerpo para tratar una afección inflamatoria (divisional de la solicitud no. 201702433)
CR20190318A (es) Compuestos heterocíclicos como inmunomoduladores
CL2017002767A1 (es) Nuevas proteínas específicas para cd137.
CL2016001609A1 (es) Composiciones farmacéuticas que comprenden azd9291.
BR112019012354A2 (pt) anticorpos apenas de cadeia pesada anti-bcma
EA201791702A1 (ru) Терапевтические средства на основе гликанов и связанные с ними способы
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
EA201991447A1 (ru) Снижение вязкости фармацевтических составов
BR112017015310A2 (pt) uso de pgr4 como um agente anti-inflamatório
MX2017004838A (es) Composiciones de interleucina-15 y usos de estas.
BR112015011933A2 (pt) composições bacterianas sinérgicas e métodos de produção e uso das mesmas
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
BR112018011228A2 (pt) tratamentos de combinação e seus usos e métodos
BR112017003346B8 (pt) Derivados de pirazolopiridina, seus usos, e composição farmacêutica
AR104835A1 (es) Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas
BR112016025876A8 (pt) composição, processos para preparar uma microcápsula e uma forma de dosagem unitária, forma de dosagem unitária, microcápsula, produto, uso de uma composição, e, método para tratar uma condição associada à vitamina k1 ou k2
CL2015000039A1 (es) Derivados estra-1,3,5(10),16-tetraeno-3-sustituidos, preparaciones farmacéuticas que los comprenden y su uso en la preparación de medicamentos para tratar la endometriosis.
PE20200338A1 (es) Composiciones cannabinoides novedosas y metodos para tratar la epilepsia infantil
CL2018001742A1 (es) Compuestos indolinones y sus usos en el tratamiento de enfermedades fibroticas.
BR112019017393A2 (pt) formulações de evolocumab de baixa viscosidade, alta concentração e métodos para produzir as mesmas
CO2017001601A2 (es) Derivados de 1-acetil-4-((pirazin-2-il) amino)-1,2,3,4-tetrahydroquinolina-6 carboxamida como inhibidores de bromodominio
JOP20190100A1 (ar) بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها
BR112016013800A2 (pt) Composições e métodos para reduzir alérgenos de gatos no ambiente
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]